In a joint statement on Tuesday, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and Argentine Health Minister Mario Lugones announced their countries’ withdrawal from the World Health Organization (WHO), criticizing its handling of the COVID-19 pandemic. The two leaders cited the organization's "structural and operational shortcomings" and called for a new international health model centered on scientific integrity, national sovereignty, and transparency.
Kennedy, during his visit to Buenos Aires, met with Argentine President Javier Milei to discuss future health cooperation between the two nations and the development of what he called an “alternative international health system.” The meeting underscores a growing alliance between the U.S. and Argentina in rethinking global health governance.
The U.S. exit follows an executive order from President Donald Trump, issued early in his second term, directing the withdrawal from WHO within a year. Trump had previously criticized the agency for alleged political bias and disproportionate U.S. financial contributions, despite the country being its largest donor. Sources revealed that the administration was open to remaining in the WHO if significant reforms were implemented, including the appointment of a U.S. director-general.
Argentina had already confirmed its departure from the WHO back in February. Tuesday’s joint declaration signals a coordinated move to challenge the status quo in global health policy, with both nations advocating for a system less influenced by international politics and more focused on accountability and scientific leadership.
This unprecedented move could reshape international health dynamics, as two major countries chart a new course away from traditional institutions and toward sovereign-driven collaboration.


Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Senate Set for Vote on GOP Healthcare Plan as Debate Over ACA Subsidies Intensifies
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Trump Administration Fuel-Efficiency Rollback Could Raise Long-Term Costs for U.S. Drivers
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges
Federal Judge Blocks Trump Administration’s Pause on New Wind-Energy Permits
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies 



